Annual Net Income
-$20.29 M
+$18.92 M+48.25%
31 December 2023
Summary:
Windtree Therapeutics annual net profit is currently -$20.29 million, with the most recent change of +$18.92 million (+48.25%) on 31 December 2023. During the last 3 years, it has risen by +$12.28 million (+37.69%). WINT annual net income is now -782.22% below its all-time high of -$2.30 million, reached on 31 December 1996.WINT Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$12.02 M
-$22.24 M-217.66%
30 June 2024
Summary:
Windtree Therapeutics quarterly net profit is currently -$12.02 million, with the most recent change of -$22.24 million (-217.66%) on 30 June 2024. Over the past year, it has dropped by -$7.60 million (-171.73%). WINT quarterly net income is now -217.66% below its all-time high of $10.22 million, reached on 31 March 2024.WINT Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$11.38 M
-$5.42 M-90.97%
30 June 2024
Summary:
Windtree Therapeutics TTM net profit is currently -$11.38 million, with the most recent change of -$5.42 million (-90.97%) on 30 June 2024. Over the past year, it has increased by +$13.45 million (+54.15%). WINT TTM net income is now -2746.00% below its all-time high of -$400.00 thousand, reached on 31 March 1995.WINT TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
WINT Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +48.3% | -171.7% | +54.1% |
| 3 y3 years | +37.7% | -46.4% | +81.6% |
| 5 y5 years | +1.2% | -68.7% | +60.9% |
WINT Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +70.0% | -217.7% | +30.6% | -91.0% | +83.2% |
| 5 y | 5 years | at high | +70.0% | -217.7% | +67.8% | -91.0% | +83.2% |
| alltime | all time | -782.2% | +70.0% | -217.7% | +67.8% | -2746.0% | +83.8% |
Windtree Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$12.02 M(-217.7%) | -$11.38 M(+91.0%) |
| Mar 2024 | - | $10.22 M(-298.3%) | -$5.96 M(-70.6%) |
| Dec 2023 | -$20.29 M(-48.2%) | -$5.15 M(+16.5%) | -$20.29 M(-18.3%) |
| Sept 2023 | - | -$4.42 M(-33.0%) | -$24.83 M(+1.5%) |
| June 2023 | - | -$6.60 M(+60.6%) | -$24.46 M(-30.5%) |
| Mar 2023 | - | -$4.11 M(-57.6%) | -$35.19 M(-10.2%) |
| Dec 2022 | -$39.21 M(-42.0%) | -$9.69 M(+139.0%) | -$39.21 M(-7.9%) |
| Sept 2022 | - | -$4.06 M(-76.6%) | -$42.59 M(-8.9%) |
| June 2022 | - | -$17.33 M(+113.3%) | -$46.75 M(-30.0%) |
| Mar 2022 | - | -$8.13 M(-37.8%) | -$66.80 M(-1.2%) |
| Dec 2021 | -$67.64 M(+107.7%) | -$13.07 M(+59.2%) | -$67.64 M(+9.1%) |
| Sept 2021 | - | -$8.21 M(-78.0%) | -$62.02 M(-1.3%) |
| June 2021 | - | -$37.39 M(+317.2%) | -$62.82 M(+79.5%) |
| Mar 2021 | - | -$8.96 M(+20.2%) | -$34.99 M(+7.5%) |
| Dec 2020 | -$32.57 M(+18.5%) | -$7.45 M(-17.4%) | -$32.57 M(+0.2%) |
| Sept 2020 | - | -$9.02 M(-5.6%) | -$32.49 M(+6.2%) |
| June 2020 | - | -$9.56 M(+46.3%) | -$30.59 M(+11.4%) |
| Mar 2020 | - | -$6.53 M(-11.4%) | -$27.47 M(-0.0%) |
| Dec 2019 | -$27.48 M(+33.8%) | -$7.38 M(+3.5%) | -$27.48 M(-5.7%) |
| Sept 2019 | - | -$7.13 M(+10.7%) | -$29.14 M(+12.3%) |
| June 2019 | - | -$6.44 M(-1.5%) | -$25.94 M(+15.0%) |
| Mar 2019 | - | -$6.54 M(-27.7%) | -$22.56 M(+9.9%) |
| Dec 2018 | -$20.53 M(+11.3%) | -$9.04 M(+130.3%) | -$20.53 M(+127.7%) |
| Sept 2018 | - | -$3.93 M(+28.7%) | -$9.02 M(-14.4%) |
| June 2018 | - | -$3.05 M(-32.4%) | -$10.53 M(-26.0%) |
| Mar 2018 | - | -$4.51 M(-282.5%) | -$14.23 M(-22.8%) |
| Dec 2017 | -$18.45 M(-53.3%) | $2.47 M(-145.4%) | -$18.45 M(-33.0%) |
| Sept 2017 | - | -$5.44 M(-19.4%) | -$27.52 M(-9.6%) |
| June 2017 | - | -$6.75 M(-22.6%) | -$30.44 M(-11.3%) |
| Mar 2017 | - | -$8.72 M(+32.1%) | -$34.31 M(-13.1%) |
| Dec 2016 | -$39.49 M(-28.4%) | -$6.60 M(-21.1%) | -$39.49 M(-8.2%) |
| Sept 2016 | - | -$8.36 M(-21.3%) | -$43.00 M(-23.5%) |
| June 2016 | - | -$10.62 M(-23.6%) | -$56.19 M(-1.2%) |
| Mar 2016 | - | -$13.90 M(+37.5%) | -$56.89 M(+3.1%) |
| Dec 2015 | -$55.17 M(+25.2%) | -$10.11 M(-53.1%) | -$55.17 M(-0.9%) |
| Sept 2015 | - | -$21.56 M(+90.3%) | -$55.70 M(+22.5%) |
| June 2015 | - | -$11.33 M(-7.0%) | -$45.46 M(+1.6%) |
| Mar 2015 | - | -$12.18 M(+14.5%) | -$44.76 M(+1.6%) |
| Dec 2014 | -$44.06 M(-2.6%) | -$10.63 M(-6.1%) | -$44.06 M(-2.4%) |
| Sept 2014 | - | -$11.32 M(+6.6%) | -$45.15 M(-2.0%) |
| June 2014 | - | -$10.62 M(-7.4%) | -$46.05 M(+4.5%) |
| Mar 2014 | - | -$11.48 M(-2.2%) | -$44.06 M(-2.6%) |
| Dec 2013 | -$45.22 M(+21.2%) | -$11.73 M(-4.0%) | -$45.22 M(+12.2%) |
| Sept 2013 | - | -$12.22 M(+41.7%) | -$40.30 M(-2.7%) |
| June 2013 | - | -$8.63 M(-31.7%) | -$41.42 M(+3.7%) |
| Mar 2013 | - | -$12.63 M(+85.4%) | -$39.93 M(+7.0%) |
| Dec 2012 | -$37.31 M(+78.0%) | -$6.82 M(-48.9%) | -$37.31 M(+7.2%) |
| Sept 2012 | - | -$13.35 M(+87.0%) | -$34.80 M(+32.8%) |
| June 2012 | - | -$7.14 M(-28.7%) | -$26.21 M(-3.5%) |
| Mar 2012 | - | -$10.02 M(+132.9%) | -$27.14 M(+29.5%) |
| Dec 2011 | -$20.96 M(+9.3%) | -$4.30 M(-9.5%) | -$20.96 M(-6.4%) |
| Sept 2011 | - | -$4.75 M(-41.2%) | -$22.40 M(-7.6%) |
| June 2011 | - | -$8.08 M(+110.5%) | -$24.24 M(+43.0%) |
| Mar 2011 | - | -$3.84 M(-33.2%) | -$16.95 M(-11.6%) |
| Dec 2010 | -$19.18 M(-35.8%) | -$5.74 M(-12.8%) | -$19.18 M(+18.2%) |
| Sept 2010 | - | -$6.58 M(+730.3%) | -$16.22 M(-12.3%) |
| June 2010 | - | -$793.00 K(-86.9%) | -$18.49 M(-27.8%) |
| Mar 2010 | - | -$6.06 M(+117.4%) | -$25.61 M(-10.3%) |
| Dec 2009 | -$29.87 M | -$2.79 M(-68.5%) | -$28.55 M(-16.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2009 | - | -$8.85 M(+11.9%) | -$34.30 M(-4.9%) |
| June 2009 | - | -$7.91 M(-12.1%) | -$36.09 M(-6.0%) |
| Mar 2009 | - | -$9.00 M(+5.4%) | -$38.39 M(-1.8%) |
| Dec 2008 | -$39.11 M(-2.2%) | -$8.54 M(-19.7%) | -$39.11 M(-8.1%) |
| Sept 2008 | - | -$10.64 M(+4.2%) | -$42.53 M(+3.1%) |
| June 2008 | - | -$10.21 M(+5.2%) | -$41.24 M(-0.4%) |
| Mar 2008 | - | -$9.71 M(-18.8%) | -$41.41 M(+3.5%) |
| Dec 2007 | -$40.01 M(-13.7%) | -$11.96 M(+28.0%) | -$40.01 M(+11.5%) |
| Sept 2007 | - | -$9.35 M(-10.0%) | -$35.89 M(+3.9%) |
| June 2007 | - | -$10.38 M(+25.0%) | -$34.54 M(-11.1%) |
| Mar 2007 | - | -$8.31 M(+5.9%) | -$38.85 M(-16.2%) |
| Dec 2006 | -$46.33 M(-21.3%) | -$7.84 M(-1.9%) | -$46.33 M(-31.7%) |
| Sept 2006 | - | -$8.00 M(-45.6%) | -$67.84 M(-3.4%) |
| June 2006 | - | -$14.70 M(-7.0%) | -$70.25 M(+7.4%) |
| Mar 2006 | - | -$15.79 M(-46.2%) | -$65.38 M(+11.0%) |
| Dec 2005 | -$58.90 M(+27.5%) | -$29.36 M(+182.1%) | -$58.90 M(+18.8%) |
| Sept 2005 | - | -$10.41 M(+5.9%) | -$49.60 M(+4.3%) |
| June 2005 | - | -$9.83 M(+5.5%) | -$47.58 M(+2.0%) |
| Mar 2005 | - | -$9.32 M(-53.5%) | -$46.65 M(+1.0%) |
| Dec 2004 | -$46.20 M(+90.3%) | -$20.05 M(+139.2%) | -$46.20 M(+32.5%) |
| Sept 2004 | - | -$8.38 M(-5.8%) | -$34.86 M(+6.6%) |
| June 2004 | - | -$8.90 M(+0.3%) | -$32.70 M(+14.1%) |
| Mar 2004 | - | -$8.87 M(+1.9%) | -$28.65 M(+18.0%) |
| Dec 2003 | -$24.28 M(+39.2%) | -$8.71 M(+40.0%) | -$24.28 M(+16.6%) |
| Sept 2003 | - | -$6.22 M(+28.3%) | -$20.83 M(+8.8%) |
| June 2003 | - | -$4.85 M(+7.6%) | -$19.14 M(+3.0%) |
| Mar 2003 | - | -$4.50 M(-14.3%) | -$18.58 M(+6.5%) |
| Dec 2002 | -$17.44 M(+56.5%) | -$5.26 M(+16.1%) | -$17.44 M(+6.4%) |
| Sept 2002 | - | -$4.53 M(+5.6%) | -$16.40 M(+14.0%) |
| June 2002 | - | -$4.29 M(+27.2%) | -$14.39 M(+15.5%) |
| Mar 2002 | - | -$3.37 M(-20.0%) | -$12.46 M(+11.8%) |
| Dec 2001 | -$11.15 M(+2.6%) | -$4.21 M(+67.2%) | -$11.15 M(+1.4%) |
| Sept 2001 | - | -$2.52 M(+7.0%) | -$10.99 M(+2.0%) |
| June 2001 | - | -$2.35 M(+14.3%) | -$10.78 M(+1.3%) |
| Mar 2001 | - | -$2.06 M(-49.2%) | -$10.64 M(+5.9%) |
| Dec 2000 | -$10.86 M(+119.1%) | -$4.05 M(+75.9%) | -$10.05 M(+42.5%) |
| Sept 2000 | - | -$2.31 M(+3.9%) | -$7.05 M(+29.5%) |
| June 2000 | - | -$2.22 M(+50.9%) | -$5.45 M(+25.8%) |
| Mar 2000 | - | -$1.47 M(+38.9%) | -$4.33 M(-10.9%) |
| Dec 1999 | -$4.96 M(-68.2%) | -$1.06 M(+51.1%) | -$4.86 M(-10.0%) |
| Sept 1999 | - | -$700.00 K(-36.4%) | -$5.40 M(-8.5%) |
| June 1999 | - | -$1.10 M(-45.0%) | -$5.90 M(-61.7%) |
| Mar 1999 | - | -$2.00 M(+25.0%) | -$15.40 M(-1.3%) |
| Dec 1998 | -$15.60 M(+69.6%) | -$1.60 M(+33.3%) | -$15.60 M(-28.1%) |
| Sept 1998 | - | -$1.20 M(-88.7%) | -$21.70 M(+4.3%) |
| June 1998 | - | -$10.60 M(+381.8%) | -$20.80 M(+66.4%) |
| Mar 1998 | - | -$2.20 M(-71.4%) | -$12.50 M(+14.7%) |
| Dec 1997 | -$9.20 M(+300.0%) | -$7.70 M(+2466.7%) | -$10.90 M(+179.5%) |
| Sept 1997 | - | -$300.00 K(-87.0%) | -$3.90 M(-11.4%) |
| June 1997 | - | -$2.30 M(+283.3%) | -$4.40 M(+76.0%) |
| Mar 1997 | - | -$600.00 K(-14.3%) | -$2.50 M(+8.7%) |
| Dec 1996 | -$2.30 M(-17.9%) | -$700.00 K(-12.5%) | -$2.30 M(+4.5%) |
| Sept 1996 | - | -$800.00 K(+100.0%) | -$2.20 M(+4.8%) |
| June 1996 | - | -$400.00 K(0.0%) | -$2.10 M(-25.0%) |
| Mar 1996 | - | -$400.00 K(-33.3%) | -$2.80 M(0.0%) |
| Dec 1995 | -$2.80 M | -$600.00 K(-14.3%) | -$2.80 M(+27.3%) |
| Sept 1995 | - | -$700.00 K(-36.4%) | -$2.20 M(+46.7%) |
| June 1995 | - | -$1.10 M(+175.0%) | -$1.50 M(+275.0%) |
| Mar 1995 | - | -$400.00 K | -$400.00 K |
FAQ
- What is Windtree Therapeutics annual net profit?
- What is the all time high annual net income for Windtree Therapeutics?
- What is Windtree Therapeutics annual net income year-on-year change?
- What is Windtree Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Windtree Therapeutics?
- What is Windtree Therapeutics quarterly net income year-on-year change?
- What is Windtree Therapeutics TTM net profit?
- What is the all time high TTM net income for Windtree Therapeutics?
- What is Windtree Therapeutics TTM net income year-on-year change?
What is Windtree Therapeutics annual net profit?
The current annual net income of WINT is -$20.29 M
What is the all time high annual net income for Windtree Therapeutics?
Windtree Therapeutics all-time high annual net profit is -$2.30 M
What is Windtree Therapeutics annual net income year-on-year change?
Over the past year, WINT annual net profit has changed by +$18.92 M (+48.25%)
What is Windtree Therapeutics quarterly net profit?
The current quarterly net income of WINT is -$12.02 M
What is the all time high quarterly net income for Windtree Therapeutics?
Windtree Therapeutics all-time high quarterly net profit is $10.22 M
What is Windtree Therapeutics quarterly net income year-on-year change?
Over the past year, WINT quarterly net profit has changed by -$7.60 M (-171.73%)
What is Windtree Therapeutics TTM net profit?
The current TTM net income of WINT is -$11.38 M
What is the all time high TTM net income for Windtree Therapeutics?
Windtree Therapeutics all-time high TTM net profit is -$400.00 K
What is Windtree Therapeutics TTM net income year-on-year change?
Over the past year, WINT TTM net profit has changed by +$13.45 M (+54.15%)